Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-SMC condensin I complex subunit G pseudogene 1 (NCAPGP1) is annotated as a pseudogene related to the non-SMC condensin I complex subunit G gene. Pseudogenes are genomic DNA sequences similar to known genes but typically do not encode functional proteins, often due to disabling mutations or lack of transcription. Some pseudogenes can be transcribed as long non-coding RNAs (lncRNAs) and may regulate gene expression through mechanisms such as microRNA sponging or antisense RNA function, as seen in other well-studied pseudogenes (e.g., PTENP1, KRAS1P)[1][3][5]. However, there is no evidence that NCAPGP1 is transcribed, functions in gene regulation, or is involved in disease. It is not considered a therapeutic target, and no drugs are known to interact with this pseudogene. The scientific consensus is that most pseudogenes, including NCAPGP1, are "biologically inert," though the field recognizes that some pseudogene transcripts can exert regulatory functions in rare cases[1][3][5]. Therefore, NCAPGP1 is not a valid molecular target or drug target, and its functional role, if any, is unknown.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-SMC condensin I complex subunit G pseudogene 1 (NCAPGP1).